Your browser doesn't support javascript.
loading
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors.
El-Khoueiry, Anthony B; Clarke, James; Neff, Tobias; Crossman, Tim; Ratia, Nirav; Rathi, Chetan; Noto, Paul; Tarkar, Aarti; Garrido-Laguna, Ignacio; Calvo, Emiliano; Rodón, Jordi; Tran, Ben; O'Dwyer, Peter J; Cuker, Adam; Abdul Razak, Albiruni R.
Afiliação
  • El-Khoueiry AB; University of Southern California Norris Comprehensive Cancer Center, 1441 Eastlake Ave, Los Angeles, CA, USA. elkhouei@med.usc.edu.
  • Clarke J; GSK, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.
  • Neff T; GSK, 1250 S Collegeville Road, Collegeville, PA, USA.
  • Crossman T; Merck&Co, North Wales, PA, USA.
  • Ratia N; GSK, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.
  • Rathi C; GSK, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.
  • Noto P; GSK, 1250 S Collegeville Road, Collegeville, PA, USA.
  • Tarkar A; GSK, 1250 S Collegeville Road, Collegeville, PA, USA.
  • Garrido-Laguna I; Adaptimmune LLC, Philadelphia, PA, USA.
  • Calvo E; GSK, 1250 S Collegeville Road, Collegeville, PA, USA.
  • Rodón J; Huntsman Cancer Institute, 2000 Cir of Hope Dr, Salt Lake City, UT, USA.
  • Tran B; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Calle Oña, 10, 28050, Madrid, Spain.
  • O'Dwyer PJ; Investigational Cancer Therapeutics Department, University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd Unit 455, 8th Floor, Houston, TX, USA.
  • Cuker A; Peter MacCallum Cancer Centre (PMCC), 305 Grattan Street, Melbourne, VIC, 3000, Australia.
  • Abdul Razak AR; University of Pennsylvania, Abramson Cancer Center, 3400 Civic Center Blvd, Philadelphia, PA, USA.
Br J Cancer ; 129(2): 309-317, 2023 08.
Article em En | MEDLINE | ID: mdl-37237172

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Tipo de estudo: Guideline Limite: Adult / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Tipo de estudo: Guideline Limite: Adult / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos